Literature DB >> 25207363

Epidemiology of skin cancer.

Ulrike Leiter, Thomas Eigentler, Claus Garbe.   

Abstract

Melanoma and nonmelanoma skin cancer (NMSC) are now the most common types of cancer in white populations. Both tumor entities show an increasing incidence rate worldwide but a stable or decreasing mortality rate. NMSC is the most common cancer in white-skinned individuals with a worldwide increasing incidence. NMSC is an increasing problem for health care services worldwide which causes significant morbidity. The rising incidence rates of NMSC are probably caused by a combination of increased exposure to ultraviolet (UV) or sun light, increased outdoor activities, changes in clothing style, increased longevity, ozone depletion, genetics and in some cases, immune suppression. An intensive UV exposure in childhood and adolescence was causative for the development of basal cell carcinoma (BCC) whereas for the etiology of SCC a chronic UV exposure in the earlier decades was accused. Cutaneous melanoma is the most rapidly increasing cancer in white populations, in the last 3 decades incidence rates have risen up to 5-fold. In 2008 melanoma was on place 5 in women and on place 8 in men of the most common solid tumor entities in Germany. The frequency of its occurrence is closely associated with the constitutive color of the skin, and the geographical zone. Changes in outdoor activities and exposure to sunlight during the past 50 years are an important factor for the increasing incidence of melanoma. Mortality rates of melanoma show a stabilization in the USA, Australia and also in European countries. In contrast to SCC, melanoma risk seems to be associated with an intermittent exposure to sunlight. Prevention campaigns aim on reducing incidence and achieving earlier diagnosis, which resulted in an ongoing trend toward thin melanoma since the last two decades. However, the impact of primary prevention measures on incidence rates of melanoma is unlikely to be seen in the near future, rather increasing incidence rates to 40-50/100,000 inhabitants/year should be expected in Europe in the next decades.

Entities:  

Mesh:

Year:  2014        PMID: 25207363     DOI: 10.1007/978-1-4939-0437-2_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  143 in total

Review 1.  Coffee consumption and the risk of cutaneous melanoma: a meta-analysis.

Authors:  Jia Wang; Xutong Li; Dongfeng Zhang
Journal:  Eur J Nutr       Date:  2015-12-22       Impact factor: 5.614

2.  Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults.

Authors:  Jennifer T Huang; Carrie C Coughlin; Elena B Hawryluk; Kristen Hook; Stephen R Humphrey; Lacey Kruse; Leslie Lawley; Hasan Al-Sayegh; Wendy B London; Ashfaq Marghoob; Thuy L Phung; Elena Pope; Pedram Gerami; Birgitta Schmidt; Sarah Robinson; Diana Bartenstein; Eman Bahrani; Meera Brahmbhatt; Lily Chen; Ellen Haddock; Danny Mansour; Julie Nguyen; Tom Raisanen; Gary Tran; Kate Travis; Zachary Wolner; Lawrence F Eichenfield
Journal:  J Pediatr       Date:  2019-05-15       Impact factor: 4.406

3.  Obesity in older adults and life expectancy with and without cardiovascular disease.

Authors:  K Dhana; M A Berghout; A Peeters; M A Ikram; H Tiemeier; A Hofman; W Nusselder; M Kavousi; O H Franco
Journal:  Int J Obes (Lond)       Date:  2016-05-10       Impact factor: 5.095

4.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

5.  Empirical redefinition of comprehensive health and well-being in the older adults of the United States.

Authors:  Martha K McClintock; William Dale; Edward O Laumann; Linda Waite
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

6.  Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia.

Authors:  Geffen Kleinstern; Abdul Rishi; Sara J Achenbach; Kari G Rabe; Neil E Kay; Tait D Shanafelt; Wei Ding; Joe F Leis; Aaron D Norman; Timothy G Call; James R Cerhan; Sameer A Parikh; Christian L Baum; Susan L Slager
Journal:  J Am Acad Dermatol       Date:  2020-07-16       Impact factor: 11.527

Review 7.  The value of metastasectomy in stage IV cutaneous melanoma.

Authors:  Uwe Wollina; Piotr Brzezinski
Journal:  Wien Med Wochenschr       Date:  2018-03-06

8.  Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting.

Authors:  Amy J Petty; Bradley Ackerson; Reed Garza; Michael Peterson; Beiyu Liu; Cynthia Green; Michelle Pavlis
Journal:  J Am Acad Dermatol       Date:  2020-01-11       Impact factor: 11.527

9.  The DNA methylation landscape of human melanoma.

Authors:  Seung-Gi Jin; Wenying Xiong; Xiwei Wu; Lu Yang; Gerd P Pfeifer
Journal:  Genomics       Date:  2015-09-15       Impact factor: 5.736

10.  Epidermal FABP Prevents Chemical-Induced Skin Tumorigenesis by Regulation of TPA-Induced IFN/p53/SOX2 Pathway in Keratinocytes.

Authors:  Yuwen Zhang; Jiaqing Hao; Jun Zeng; Qiang Li; Enyu Rao; Yanwen Sun; Lianliang Liu; Anita Mandal; V Douglas Landers; Rebecca J Morris; Margot P Cleary; Jill Suttles; Bing Li
Journal:  J Invest Dermatol       Date:  2018-03-17       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.